Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus

David P. Eisenberg, Prasad S. Adusumilli, Karen J. Hendershott, Sun M. Chung, Zhenkun Yu, Mei Ki Chan, Michael Hezel, Richard J. Wong, Yuman Fong

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

OBJECTIVE: To investigate the use of a green fluorescent protein (GFP)-expressing oncolytic herpes virus to enable real-time intraoperative detection of breast cancer lymph node metastases. SUMMARY BACKGROUND DATA: Axillary lymph node status is the most important factor determining treatment, recurrence, and overall survival for women with breast cancer. The current methods of determining nodal status, however, have limitations. NV1066 is a novel oncolytic herpes viral strain that specifically infects cancer cells and expresses GFP. METHODS: Seven human breast cancer cell lines were infected in vitro with NV1066 and assessed for GFP expression, viral replication, and cytotoxicity. An in vivo model of breast cancer lymphatic metastasis was established in mice. Tumor-bearing mice were treated with NV1066 via injection into the primary tumor. Axillary lymph nodes were analyzed using an in vivo fluorescent imaging system. Histologic and molecular assessment of lymph nodes were performed using immunohistochemistry and reverse transcriptase PCR and operating characteristics were determined. RESULTS: NV1066 infected, expressed GFP, replicated within, and killed all human breast cancer cell lines in vitro. Injection of NV1066 into primary breast tumors resulted in viral transit to axillary lymph nodes, infection of lymphatic metastases, and GFP expression that was visualized with in vivo fluorescent imaging. Histologic and molecular confirmation demonstrated favorable operating characteristics of this method (sensitivity 80%; specificity 96%). CONCLUSIONS: We introduce a novel, sensitive, and specific method of lymphatic mapping that utilizes NV1066-guided cancer cell-specific viral production of GFP to enable real-time intraoperative detection of lymphatic metastases.

Original languageEnglish (US)
Pages (from-to)824-830
Number of pages7
JournalAnnals of Surgery
Volume243
Issue number6
DOIs
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Green Fluorescent Proteins
Lymph Nodes
Breast Neoplasms
Neoplasm Metastasis
Viruses
Lymphatic Metastasis
Neoplasms
Oncolytic Viruses
Cell Line
Injections
Reverse Transcriptase Polymerase Chain Reaction
Immunohistochemistry
Recurrence
Survival
Infection

ASJC Scopus subject areas

  • Surgery

Cite this

Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus. / Eisenberg, David P.; Adusumilli, Prasad S.; Hendershott, Karen J.; Chung, Sun M.; Yu, Zhenkun; Chan, Mei Ki; Hezel, Michael; Wong, Richard J.; Fong, Yuman.

In: Annals of Surgery, Vol. 243, No. 6, 06.2006, p. 824-830.

Research output: Contribution to journalArticle

Eisenberg, David P. ; Adusumilli, Prasad S. ; Hendershott, Karen J. ; Chung, Sun M. ; Yu, Zhenkun ; Chan, Mei Ki ; Hezel, Michael ; Wong, Richard J. ; Fong, Yuman. / Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus. In: Annals of Surgery. 2006 ; Vol. 243, No. 6. pp. 824-830.
@article{ad49010674054bf4a2643e422afa3c73,
title = "Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus",
abstract = "OBJECTIVE: To investigate the use of a green fluorescent protein (GFP)-expressing oncolytic herpes virus to enable real-time intraoperative detection of breast cancer lymph node metastases. SUMMARY BACKGROUND DATA: Axillary lymph node status is the most important factor determining treatment, recurrence, and overall survival for women with breast cancer. The current methods of determining nodal status, however, have limitations. NV1066 is a novel oncolytic herpes viral strain that specifically infects cancer cells and expresses GFP. METHODS: Seven human breast cancer cell lines were infected in vitro with NV1066 and assessed for GFP expression, viral replication, and cytotoxicity. An in vivo model of breast cancer lymphatic metastasis was established in mice. Tumor-bearing mice were treated with NV1066 via injection into the primary tumor. Axillary lymph nodes were analyzed using an in vivo fluorescent imaging system. Histologic and molecular assessment of lymph nodes were performed using immunohistochemistry and reverse transcriptase PCR and operating characteristics were determined. RESULTS: NV1066 infected, expressed GFP, replicated within, and killed all human breast cancer cell lines in vitro. Injection of NV1066 into primary breast tumors resulted in viral transit to axillary lymph nodes, infection of lymphatic metastases, and GFP expression that was visualized with in vivo fluorescent imaging. Histologic and molecular confirmation demonstrated favorable operating characteristics of this method (sensitivity 80{\%}; specificity 96{\%}). CONCLUSIONS: We introduce a novel, sensitive, and specific method of lymphatic mapping that utilizes NV1066-guided cancer cell-specific viral production of GFP to enable real-time intraoperative detection of lymphatic metastases.",
author = "Eisenberg, {David P.} and Adusumilli, {Prasad S.} and Hendershott, {Karen J.} and Chung, {Sun M.} and Zhenkun Yu and Chan, {Mei Ki} and Michael Hezel and Wong, {Richard J.} and Yuman Fong",
year = "2006",
month = "6",
doi = "10.1097/01.sla.0000219738.56896.c0",
language = "English (US)",
volume = "243",
pages = "824--830",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus

AU - Eisenberg, David P.

AU - Adusumilli, Prasad S.

AU - Hendershott, Karen J.

AU - Chung, Sun M.

AU - Yu, Zhenkun

AU - Chan, Mei Ki

AU - Hezel, Michael

AU - Wong, Richard J.

AU - Fong, Yuman

PY - 2006/6

Y1 - 2006/6

N2 - OBJECTIVE: To investigate the use of a green fluorescent protein (GFP)-expressing oncolytic herpes virus to enable real-time intraoperative detection of breast cancer lymph node metastases. SUMMARY BACKGROUND DATA: Axillary lymph node status is the most important factor determining treatment, recurrence, and overall survival for women with breast cancer. The current methods of determining nodal status, however, have limitations. NV1066 is a novel oncolytic herpes viral strain that specifically infects cancer cells and expresses GFP. METHODS: Seven human breast cancer cell lines were infected in vitro with NV1066 and assessed for GFP expression, viral replication, and cytotoxicity. An in vivo model of breast cancer lymphatic metastasis was established in mice. Tumor-bearing mice were treated with NV1066 via injection into the primary tumor. Axillary lymph nodes were analyzed using an in vivo fluorescent imaging system. Histologic and molecular assessment of lymph nodes were performed using immunohistochemistry and reverse transcriptase PCR and operating characteristics were determined. RESULTS: NV1066 infected, expressed GFP, replicated within, and killed all human breast cancer cell lines in vitro. Injection of NV1066 into primary breast tumors resulted in viral transit to axillary lymph nodes, infection of lymphatic metastases, and GFP expression that was visualized with in vivo fluorescent imaging. Histologic and molecular confirmation demonstrated favorable operating characteristics of this method (sensitivity 80%; specificity 96%). CONCLUSIONS: We introduce a novel, sensitive, and specific method of lymphatic mapping that utilizes NV1066-guided cancer cell-specific viral production of GFP to enable real-time intraoperative detection of lymphatic metastases.

AB - OBJECTIVE: To investigate the use of a green fluorescent protein (GFP)-expressing oncolytic herpes virus to enable real-time intraoperative detection of breast cancer lymph node metastases. SUMMARY BACKGROUND DATA: Axillary lymph node status is the most important factor determining treatment, recurrence, and overall survival for women with breast cancer. The current methods of determining nodal status, however, have limitations. NV1066 is a novel oncolytic herpes viral strain that specifically infects cancer cells and expresses GFP. METHODS: Seven human breast cancer cell lines were infected in vitro with NV1066 and assessed for GFP expression, viral replication, and cytotoxicity. An in vivo model of breast cancer lymphatic metastasis was established in mice. Tumor-bearing mice were treated with NV1066 via injection into the primary tumor. Axillary lymph nodes were analyzed using an in vivo fluorescent imaging system. Histologic and molecular assessment of lymph nodes were performed using immunohistochemistry and reverse transcriptase PCR and operating characteristics were determined. RESULTS: NV1066 infected, expressed GFP, replicated within, and killed all human breast cancer cell lines in vitro. Injection of NV1066 into primary breast tumors resulted in viral transit to axillary lymph nodes, infection of lymphatic metastases, and GFP expression that was visualized with in vivo fluorescent imaging. Histologic and molecular confirmation demonstrated favorable operating characteristics of this method (sensitivity 80%; specificity 96%). CONCLUSIONS: We introduce a novel, sensitive, and specific method of lymphatic mapping that utilizes NV1066-guided cancer cell-specific viral production of GFP to enable real-time intraoperative detection of lymphatic metastases.

UR - http://www.scopus.com/inward/record.url?scp=33745291501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745291501&partnerID=8YFLogxK

U2 - 10.1097/01.sla.0000219738.56896.c0

DO - 10.1097/01.sla.0000219738.56896.c0

M3 - Article

C2 - 16772786

AN - SCOPUS:33745291501

VL - 243

SP - 824

EP - 830

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 6

ER -